Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. has demonstrated a positive revenue trajectory, with a 1.6% year-over-year increase in product and services, exceeding the company's forecasts due in part to strategic timing of deals. The company is positioning itself for future growth through the burgeoning popularity of its technologies, particularly Atmos and Vision, which are expected to drive higher per-unit royalties as market volumes recover. Additionally, Dolby's initiatives to implement SaaS-like models associated with patent licensing and its OptiView solution could further bolster its financial performance in the coming years.

Bears say

Dolby Laboratories Inc. is projected to experience a significant decline in revenue, with estimates suggesting a 7.5% year-over-year decrease in License Revenue and a 5.7% drop in Products/Services for the December quarter. The company is also anticipating a high-single-digit revenue decline for fiscal 2026, mirroring the trends seen in fiscal 2025, further compounded by declining margins in its Products/Services segment, which contributed to a decrease in gross margins from 90.8% to 89.8%. Additionally, challenges in device volumes, particularly following the pandemic-driven purchasing surge, and overall lower expectations within the PC and consumer electronics sectors, position Dolby Laboratories at a disadvantage in the near term.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.